1 Department of Rheumatology and Immunology, Peking University International Hospital, Beijing, China 2 Department of Pathology, Peking University International Hospital, Beijing, China ...

Avacopan is under clinical development by Amgen and currently in Phase III for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis). According to GlobalData, Phase III drugs ...

Neutrophils are rapidly recruited to sites of infection, injury, or to immune complexes. Upon arrival, they initiate degranulation, release reactive oxygen species (ROS), and/or nuclear extracellular ...

Iptacopan hydrochloride is under clinical development by Novartis and currently in Phase II for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis). According to GlobalData, ...